Table 2 Non-susceptibility a rates (%) for the total isolate yield of the study (n = 563)
Antimicrobial agent | Escherichia coli (n = 330) | Klebsiella spp (n = 91) | Proteus mirabilis (n = 142) |
|---|---|---|---|
Amoxicillin | 31.5 | N/A b | 33.1 |
Amoxicillin/clavulanic acid | 6.4 | 1.1 | 4.2 |
Cefalothin | 9.1 | 3.3 | 13.4 |
Cefuroxime sodium | 2.7 | 1.1 | 1.4 |
Cefuroxime axetil | 3.9 | 3.3 | 2.8 |
Co-trimoxazole | 23.6 | 11.0 | 13.4 |
Nalidixic acid | 8.2 | 9.9 | 5.6 |
Ciprofloxacin | 4.8 | 5.5 | 1.4 |
Mecillinam | 3.6 | 1.1 | 22.5 |
Nitrofurantoin | 6.4 | 30.8 | N/A b |
Fosfomycin c | 1.2 | 1.1 | 9.9 |
Cefotaxime | 3.0 | 1.1 | 1.4 |
Ceftazidime | 0.6 | 1.1 | 3.5 |
Gentamicin | 2.1 | 1.1 | 4.2 |
Netilimicin | 0.6 | 1.1 | 0.7 |
Amikacin | 0.9 | 1.1 | 0 |
Piperacillin-tazobactam | 0.6 | 1.1 | 0 |
Ticarcillin-clavulanate | 0.9 | 1.1 | 0.7 |
Imipenem | 0.6 | 0 | 0.7 |
Cefditoren | 3.0 | 3.3 | 2.1 |